• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“卡巴”-卡芬太尼(反式异构体):一种具有独特结合模式的μ阿片受体(MOR)部分激动剂。

'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode.

作者信息

Weltrowska Grazyna, Lemieux Carole, Chung Nga N, Guo Jason J, Wilkes Brian C, Schiller Peter W

机构信息

Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, QC H2W 1R7, Canada.

Center for Drug Discovery, Northeastern University, 360 Huntington Avenue, Boston, MA 02115, USA.

出版信息

Bioorg Med Chem. 2014 Sep 1;22(17):4581-6. doi: 10.1016/j.bmc.2014.07.033. Epub 2014 Jul 29.

DOI:10.1016/j.bmc.2014.07.033
PMID:25129170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4149825/
Abstract

There is strong evidence to indicate that a positively charged nitrogen of endogenous and exogenous opioid ligands forms a salt bridge with the Asp residue in the third transmembrane helix of opioid receptors. To further examine the role of this electrostatic interaction in opioid receptor binding and activation, we synthesized 'carba'-analogues of the highly potent μ opioid analgesic carfentanil (3), in which the piperidine nitrogen was replaced with a carbon. The resulting trans isomer (8b) showed reduced, but still significant MOR binding affinity (Ki(μ)=95.2nM) with no MOR versus DOR binding selectivity and was a MOR partial agonist. The cis isomer (8a) was essentially inactive. A MOR docking study indicated that 8b bound to the same binding pocket as parent 3, but its binding mode was somewhat different. A re-evaluation of the uncharged morphine derivative N-formylnormorphine (9) indicated that it was a weak MOR antagonist showing no preference for MOR over KOR. Taken together, the results indicate that deletion of the positively charged nitrogen in μ opioid analgesics reduces MOR binding affinity by 2-3 orders of magnitude and may have pronounced effects on the intrinsic efficacy and on the opioid receptor selectivity profile.

摘要

有强有力的证据表明,内源性和外源性阿片样物质配体带正电荷的氮原子与阿片受体第三个跨膜螺旋中的天冬氨酸残基形成盐桥。为了进一步研究这种静电相互作用在阿片受体结合和激活中的作用,我们合成了强效μ阿片类镇痛药卡芬太尼(3)的“碳环”类似物,其中哌啶氮被碳取代。所得反式异构体(8b)显示出降低但仍显著的MOR结合亲和力(Ki(μ)=95.2nM),对MOR与DOR没有结合选择性,并且是MOR部分激动剂。顺式异构体(8a)基本无活性。一项MOR对接研究表明,8b与母体3结合在相同的结合口袋中,但其结合模式有所不同。对不带电荷的吗啡衍生物N-甲酰去甲吗啡(9)的重新评估表明,它是一种弱MOR拮抗剂,对MOR和KOR没有偏好。综上所述,结果表明,μ阿片类镇痛药中带正电荷氮原子的缺失使MOR结合亲和力降低2-3个数量级,并且可能对内在效力和阿片受体选择性谱产生显著影响。

相似文献

1
'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode.“卡巴”-卡芬太尼(反式异构体):一种具有独特结合模式的μ阿片受体(MOR)部分激动剂。
Bioorg Med Chem. 2014 Sep 1;22(17):4581-6. doi: 10.1016/j.bmc.2014.07.033. Epub 2014 Jul 29.
2
"Carba"-analogues of fentanyl are opioid receptor agonists."Carba"-类似物芬太尼是阿片受体激动剂。
J Med Chem. 2010 Apr 8;53(7):2875-81. doi: 10.1021/jm9019068.
3
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.取代芬太尼对阿片受体的亲和力、效价、效能、选择性及分子模拟
Biochem Pharmacol. 2020 Dec;182:114293. doi: 10.1016/j.bcp.2020.114293. Epub 2020 Oct 20.
4
Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.使用乌吉多组分反应合成卡芬太尼酰胺类阿片药物。
ACS Chem Neurosci. 2015 Sep 16;6(9):1570-7. doi: 10.1021/acschemneuro.5b00137. Epub 2015 Jul 21.
5
Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation.μ 型阿片受体芬太尼类拮抗剂:轴向手性在活性构象中的重要作用。
J Med Chem. 2024 Jun 27;67(12):10447-10463. doi: 10.1021/acs.jmedchem.4c00935. Epub 2024 Jun 13.
6
Design, Synthesis, and Structure-Activity Relationship Exploration of Alkyl/Phenylalkyl Piperidine Analogues as Novel Highly Potent and Selective μ Opioid Receptor Agonists.烷基/苯烷基哌啶类似物的设计、合成及构效关系研究作为新型高效和选择性μ阿片受体激动剂。
ACS Chem Neurosci. 2021 Jan 20;12(2):285-299. doi: 10.1021/acschemneuro.0c00487. Epub 2020 Dec 28.
7
Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.阿片肽受体研究。7. 甲基芬太尼同系物RTI-4614-4及其四种对映体与大鼠μ阿片受体的不同结构域结合。
Synapse. 1998 Feb;28(2):117-24. doi: 10.1002/(SICI)1098-2396(199802)28:2<117::AID-SYN2>3.0.CO;2-E.
8
How μ-opioid receptor recognizes fentanyl.μ-阿片受体如何识别芬太尼。
Nat Commun. 2021 Feb 12;12(1):984. doi: 10.1038/s41467-021-21262-9.
9
Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.生物可利用的、具有混合效应的μ-阿片受体(MOR)激动剂/δ-阿片受体(DOR)拮抗剂的进一步优化与评估:平衡MOR和DOR亲和力
J Med Chem. 2015 Nov 25;58(22):8952-69. doi: 10.1021/acs.jmedchem.5b01270. Epub 2015 Nov 13.
10
Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.G 蛋白偏向性和非偏向性μ阿片受体配体在雄性和雌性大鼠温水尾部退缩和药物辨别中的有效性比较。
Neuropharmacology. 2019 May 15;150:200-209. doi: 10.1016/j.neuropharm.2019.01.020. Epub 2019 Jan 18.

引用本文的文献

1
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits.丁丙诺啡的药效学:理解丁丙诺啡临床益处的桥梁。
Drugs. 2025 Feb;85(2):215-230. doi: 10.1007/s40265-024-02128-y. Epub 2025 Jan 28.
2
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder.《扩大丁丙诺啡使用范围以治疗阿片类药物使用障碍:指南》
Drugs R D. 2023 Dec;23(4):339-362. doi: 10.1007/s40268-023-00443-5. Epub 2023 Nov 8.
3
Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis.芬太尼家族在μ-阿片受体上的作用:结合的统一评估和计算分析。
Molecules. 2019 Feb 19;24(4):740. doi: 10.3390/molecules24040740.
4
Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil.芬太尼类药物在毒品领域持续取代海洛因:奥芬太尼和卡芬太尼的案例。
Forensic Toxicol. 2018;36(1):12-32. doi: 10.1007/s11419-017-0379-4. Epub 2017 Aug 18.

本文引用的文献

1
Modulation of opioid receptor ligand affinity and efficacy using active and inactive state receptor models.利用激活态和失活态受体模型调节阿片受体配体亲和力和效能。
Chem Biol Drug Des. 2012 Nov;80(5):763-70. doi: 10.1111/cbdd.12014. Epub 2012 Sep 12.
2
Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist.新型κ-阿片受体拮抗剂CJ-15,208的合成
Tetrahedron Lett. 2010 Sep 20;51(38):5020-5023. doi: 10.1016/j.tetlet.2010.07.086.
3
Structure of the δ-opioid receptor bound to naltrindole.δ-阿片受体与纳曲吲哚结合的结构。
Nature. 2012 May 16;485(7398):400-4. doi: 10.1038/nature11111.
4
Structure of the human κ-opioid receptor in complex with JDTic.人κ-阿片受体与 JDTic 复合物的结构。
Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939.
5
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.μ-阿片受体与吗啡喃拮抗剂结合的晶体结构
Nature. 2012 Mar 21;485(7398):321-6. doi: 10.1038/nature10954.
6
"Carba"-analogues of fentanyl are opioid receptor agonists."Carba"-类似物芬太尼是阿片受体激动剂。
J Med Chem. 2010 Apr 8;53(7):2875-81. doi: 10.1021/jm9019068.
7
Cyclic opioid peptide agonists and antagonists obtained via ring-closing metathesis.通过闭环复分解反应获得的环状阿片肽激动剂和拮抗剂。
Chem Biol Drug Des. 2009 Oct;74(4):329-34. doi: 10.1111/j.1747-0285.2009.00867.x. Epub 2009 Aug 20.
8
Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor.构建基于结构的萨尔文诺林A与κ-阿片受体识别模型。
J Med Chem. 2008 Mar 27;51(6):1824-30. doi: 10.1021/jm701040v. Epub 2008 Feb 23.
9
Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.新克罗烷二萜类化合物作为μ阿片受体配体的新型骨架。
J Med Chem. 2005 Jul 28;48(15):4765-71. doi: 10.1021/jm048963m.
10
Synthesis and evaluation of the affinity toward mu-opioid receptors of atypical, lipophilic ligands based on the sequence c[-Tyr-Pro-Trp-Phe-Gly-].基于序列c[-酪氨酸-脯氨酸-色氨酸-苯丙氨酸-甘氨酸-]的非典型亲脂性配体对μ-阿片受体亲和力的合成与评价
J Med Chem. 2004 Oct 7;47(21):5198-203. doi: 10.1021/jm0498811.